Intention-to-treat analysis
From TrialTree Wiki
Intention-to-Treat (ITT) Analysis
Intention-to-Treat (ITT) Analysis is a fundamental principle in the analysis of randomized controlled trials (RCTs). It ensures that all participants are analyzed in the group to which they were originally randomized, regardless of their adherence to the intervention, withdrawal, or deviations from the protocol. ITT is widely regarded as the gold standard approach for preserving the benefits of randomization and minimizing bias.
Why Use ITT Analysis?
There are several reasons to use ITT analysis:
- Maintains Randomization: Ensures that treatment groups remain comparable and the randomization process is preserved.
- Reduces Bias: Accounts for real-world challenges such as non-adherence and missing data.
- Reflects Clinical Reality: Offers a pragmatic estimate of how effective an intervention is under typical conditions.
Key Steps in ITT Analysis
1. Include All Randomized Participants: Regardless of whether participants adhered to the intervention, dropped out, or crossed over to another group.
2. Handle Missing Data Appropriately: Use statistical methods such as last observation carried forward (LOCF), multiple imputation (MI), or inverse probability weighting (IPW).
3. Analyze Based on Initial Assignment: Participants are analyzed according to the group they were originally randomized to, even if they received a different intervention.
Methods to Handle Missing Data in ITT
Missing data is common in ITT analysis. The following approaches are commonly used:
- Complete Case Analysis (CCA): Includes only participants with complete data, but may introduce bias if missingness is non-random.
- Last Observation Carried Forward (LOCF): Assumes the last recorded value remains unchanged, which may be overly simplistic.
- Multiple Imputation (MI): Uses statistical models to estimate missing values based on observed data.
- Inverse Probability Weighting (IPW): Weights participants based on their likelihood of remaining in the study.
ITT vs. Per-Protocol (PP) Analysis
| Aspect | Intention-to-Treat (ITT) | Per-Protocol (PP) |
|---|---|---|
| Participants Included | All randomized participants | Only those who adhered to the intervention protocol |
| Effect Estimate | Real-world effectiveness | Ideal treatment efficacy |
| Bias Risk | Lower (minimizes exclusion bias) | Higher (exclusions can introduce bias) |
| Clinical Relevance | High (reflects typical clinical settings) | Lower (less applicable to real-world practice) |
Statistical Considerations
- Use statistical methods suitable for repeated measures, such as generalized estimating equations (GEE) or mixed-effects models.
- Apply multiple imputation or other appropriate techniques to address missing data.
- Conduct sensitivity analyses to compare ITT results with per-protocol analyses and assess robustness.
Reporting ITT in RCTs
To ensure transparency and reproducibility:
- Clearly state that ITT analysis was used.
- Specify the method used to handle missing data.
- Follow CONSORT guidelines to report exclusions and protocol deviations.
Conclusion
Intention-to-Treat (ITT) analysis is essential for preserving the integrity of randomization and for producing results that are applicable to real-world clinical settings. By including all randomized participants regardless of adherence, ITT minimizes bias and provides a conservative and pragmatic estimate of treatment effect. It should be clearly specified and reported in all RCTs.
Bibliography
- Gupta SK. Intention-to-treat concept: a review. Perspectives in Clinical Research. 2011;2(3):109–112.
- Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319(7211):670–674.
- Lachin JM. Statistical considerations in the intent-to-treat principle. Controlled Clinical Trials. 2000;21(3):167–189.
- Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ. 2001;165(10):1339–1341.
- White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ. 2011;342:d40.
Adapted for educational use. Please cite relevant trial methodology sources when using this material in research or teaching.